Hancock Whitney Corp Sells 1,515 Shares of Crocs, Inc. (NASDAQ:CROX)

Hancock Whitney Corp decreased its holdings in Crocs, Inc. (NASDAQ:CROX) by 15.4% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 8,300 shares of the textile maker’s stock after selling 1,515 shares during the quarter. Hancock Whitney Corp’s holdings in Crocs were worth $1,211,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. Nisa Investment Advisors LLC boosted its holdings in Crocs by 8.9% during the second quarter. Nisa Investment Advisors LLC now owns 1,041 shares of the textile maker’s stock worth $152,000 after purchasing an additional 85 shares during the last quarter. Riverwater Partners LLC boosted its stake in shares of Crocs by 1.0% in the 1st quarter. Riverwater Partners LLC now owns 10,725 shares of the textile maker’s stock worth $1,542,000 after buying an additional 104 shares during the last quarter. 180 Wealth Advisors LLC grew its holdings in shares of Crocs by 1.6% in the second quarter. 180 Wealth Advisors LLC now owns 7,248 shares of the textile maker’s stock valued at $1,036,000 after acquiring an additional 111 shares in the last quarter. Assetmark Inc. increased its position in shares of Crocs by 1.6% during the fourth quarter. Assetmark Inc. now owns 8,828 shares of the textile maker’s stock valued at $825,000 after acquiring an additional 142 shares during the last quarter. Finally, Blue Trust Inc. lifted its holdings in Crocs by 19.3% during the second quarter. Blue Trust Inc. now owns 1,001 shares of the textile maker’s stock worth $144,000 after acquiring an additional 162 shares during the period. Institutional investors and hedge funds own 93.44% of the company’s stock.

Crocs Price Performance

CROX opened at $139.05 on Monday. The company has a current ratio of 1.50, a quick ratio of 0.95 and a debt-to-equity ratio of 0.93. The stock has a market capitalization of $8.44 billion, a P/E ratio of 10.76, a PEG ratio of 1.29 and a beta of 2.00. The stock has a 50-day moving average price of $134.34 and a 200-day moving average price of $137.93. Crocs, Inc. has a 12-month low of $74.00 and a 12-month high of $165.32.

Crocs (NASDAQ:CROX) last announced its quarterly earnings data on Thursday, August 1st. The textile maker reported $4.01 earnings per share for the quarter, topping analysts’ consensus estimates of $3.59 by $0.42. Crocs had a net margin of 20.02% and a return on equity of 53.20%. The firm had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.10 billion. During the same period in the previous year, the business posted $3.59 EPS. The business’s quarterly revenue was up 3.6% on a year-over-year basis. Equities analysts predict that Crocs, Inc. will post 12.85 earnings per share for the current fiscal year.

Insider Buying and Selling at Crocs

In related news, Director Douglas J. Treff sold 10,594 shares of the business’s stock in a transaction dated Thursday, August 8th. The stock was sold at an average price of $132.38, for a total transaction of $1,402,433.72. Following the transaction, the director now owns 81,254 shares in the company, valued at approximately $10,756,404.52. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, Director John B. Replogle purchased 1,996 shares of the firm’s stock in a transaction that occurred on Friday, August 2nd. The stock was bought at an average cost of $123.96 per share, with a total value of $247,424.16. Following the completion of the purchase, the director now directly owns 7,064 shares in the company, valued at $875,653.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Douglas J. Treff sold 10,594 shares of Crocs stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $132.38, for a total value of $1,402,433.72. Following the sale, the director now directly owns 81,254 shares in the company, valued at $10,756,404.52. The disclosure for this sale can be found here. Corporate insiders own 2.72% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on CROX. StockNews.com upgraded Crocs from a “hold” rating to a “buy” rating in a research note on Friday, August 23rd. UBS Group lowered their price objective on shares of Crocs from $148.00 to $146.00 and set a “neutral” rating on the stock in a research report on Tuesday, July 16th. Williams Trading raised shares of Crocs from a “hold” rating to a “buy” rating and increased their target price for the company from $135.00 to $163.00 in a research report on Thursday, August 22nd. Piper Sandler reaffirmed an “overweight” rating and issued a $170.00 price target on shares of Crocs in a report on Friday, August 23rd. Finally, Barclays dropped their price objective on Crocs from $169.00 to $164.00 and set an “overweight” rating on the stock in a research note on Friday, August 2nd. Two research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $160.27.

About Crocs

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.